Cargando…
Gypenoside Attenuates β Amyloid-Induced Inflammation in N9 Microglial Cells via SOCS1 Signaling
Reducing β amyloid- (Aβ-) induced microglial activation is believed to be effective in treating Alzheimer's disease (AD). Microglia can be activated into classic activated state (M1 state) or alternative activated state (M2 state), and the former is harmful; in contrast, the latter is beneficia...
Autores principales: | Cai, Hui, Liang, Qianlei, Ge, Guanqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861811/ https://www.ncbi.nlm.nih.gov/pubmed/27213058 http://dx.doi.org/10.1155/2016/6362707 |
Ejemplares similares
-
SOCS1 Mediates Berberine-Induced Amelioration of Microglial Activated States in N9 Microglia Exposed to β Amyloid
por: Guo, Qi, et al.
Publicado: (2021) -
Resveratrol Attenuates Microglial Activation via SIRT1-SOCS1 Pathway
por: Zhang, Shuping, et al.
Publicado: (2017) -
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011) -
Gypenosides Attenuate Lipopolysaccharide-Induced Neuroinflammation and Memory Impairment in Rats
por: Lee, Bombi, et al.
Publicado: (2018) -
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C
por: Jia, Ji, et al.
Publicado: (2016)